Man Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,764
| Closed | -$8.6M | – | 2503 |
|
|
2025
Q4 | $8.6M | Sell |
14,764
-6,564
| -31% | -$3.35M | 0.02% | 866 |
|
|
2025
Q3 | $9.78M | Buy |
21,328
+19,961
| +1,460% | +$7.45M | 0.02% | 802 |
|
|
2025
Q2 | $414K | Buy |
+1,367
| New | +$407K | ﹤0.01% | 1887 |
|
|
2025
Q1 | – | Sell |
-8,498
| Closed | -$2.62M | – | 2295 |
|
|
2024
Q4 | $2.62M | Buy |
+8,498
| New | +$2.39M | 0.01% | 1236 |
|
|
2023
Q4 | – | Hold |
0
| – | -$3.14M | – | 2174 |
|
|
2023
Q3 | – | Sell |
-19,281
| Closed | -$3.63M | – | 1035 |
|
|
2023
Q2 | $4.45M | Buy |
+19,281
| New | +$5.22M | 0.01% | 919 |
|
|
2022
Q4 | – | Sell |
-7,600
| Closed | -$494K | – | 2118 |
|
|
2022
Q3 | $494K | Buy |
+7,600
| New | +$528K | ﹤0.01% | 1523 |
|
|
2022
Q1 | – | Sell |
-18,700
| Closed | -$1.58M | – | 2285 |
|
|
2021
Q4 | $1.58M | Hold |
18,700
| – | – | 0.01% | 1228 |
|
|
2021
Q3 | $1.49M | Hold |
18,700
| – | – | 0.01% | 1252 |
|
|
2021
Q2 | $1.82M | Buy |
18,700
+4,600
| +33% | +$545K | 0.01% | 1247 |
|
|
2021
Q1 | $1.65M | Buy |
+14,100
| New | +$1.64M | 0.01% | 1167 |
|
|
2019
Q2 | – | Sell |
-31,848
| Closed | -$3.99M | – | 1954 |
|
|
2019
Q1 | $3.99M | Sell |
31,848
-29,208
| -48% | -$3.63M | 0.02% | 1035 |
|
|
2018
Q4 | $6.88M | Buy |
61,056
+27,934
| +84% | +$4.32M | 0.03% | 608 |
|
|
2018
Q3 | $7.09M | Buy |
33,122
+11,503
| +53% | +$2.89M | 0.03% | 803 |
|
|
2018
Q2 | $6.05M | Buy |
+21,619
| New | +$3.8M | 0.03% | 843 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
